Silverlake Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $270K | Buy |
5,835
+269
| +5% | +$12.5K | 0.08% | 263 |
|
|
2025
Q1 | $339K | Buy |
5,566
+3
| +0.1% | +$183 | 0.13% | 169 |
|
|
2024
Q4 | $315K | Buy |
5,563
+2
| +0% | +$113 | 0.12% | 182 |
|
|
2024
Q3 | $288K | Buy |
5,561
+3
| +0.1% | +$155 | 0.11% | 208 |
|
|
2024
Q2 | $231K | Buy |
5,558
+3
| +0.1% | +$125 | 0.09% | 237 |
|
|
2024
Q1 | $301K | Buy |
5,555
+2
| +0% | +$108 | 0.15% | 172 |
|
|
2023
Q4 | $285K | Sell |
5,553
-621
| -10% | -$31.9K | 0.16% | 167 |
|
|
2023
Q3 | $358K | Buy |
6,174
+33
| +0.5% | +$1.92K | 0.2% | 140 |
|
|
2023
Q2 | $393K | Sell |
6,141
-28
| -0.5% | -$1.79K | 0.22% | 119 |
|
|
2023
Q1 | $428K | Sell |
6,169
-1,211
| -16% | -$83.9K | 0.26% | 104 |
|
|
2022
Q4 | $531K | Buy |
7,380
+4
| +0.1% | +$288 | 0.33% | 71 |
|
|
2022
Q3 | $524K | Sell |
7,376
-3
| -0% | -$213 | 0.36% | 73 |
|
|
2022
Q2 | $568K | Buy |
7,379
+136
| +2% | +$10.5K | 0.37% | 70 |
|
|
2022
Q1 | $529K | Buy |
7,243
+95
| +1% | +$6.94K | 0.3% | 80 |
|
|
2021
Q4 | $446K | Buy |
+7,148
| New | +$446K | 0.24% | 107 |
|